| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 2.40e-04 | 21 | 22 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 6.36e-04 | 34 | 22 | 2 | GO:0046966 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 7.54e-04 | 37 | 22 | 2 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 7.95e-04 | 38 | 22 | 2 | GO:0070001 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.07e-03 | 739 | 22 | 5 | GO:0003682 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.09e-03 | 187 | 22 | 3 | GO:0016922 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 1.54e-03 | 53 | 22 | 2 | GO:0030331 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 2.04e-03 | 61 | 22 | 2 | GO:0030374 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 4.30e-03 | 303 | 22 | 3 | GO:0003713 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 5.58e-03 | 102 | 22 | 2 | GO:0016410 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 3.75e-04 | 1377 | 22 | 7 | GO:0140513 | |
| Domain | Bromodomain_CS | 3.49e-04 | 26 | 20 | 2 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 7.09e-04 | 37 | 20 | 2 | PS00633 | |
| Domain | Bromodomain | 7.48e-04 | 38 | 20 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 8.71e-04 | 41 | 20 | 2 | PS50014 | |
| Domain | BROMO | 9.14e-04 | 42 | 20 | 2 | SM00297 | |
| Domain | Bromodomain | 9.14e-04 | 42 | 20 | 2 | IPR001487 | |
| Domain | - | 9.14e-04 | 42 | 20 | 2 | 1.20.920.10 | |
| Domain | Homeodomain-like | 5.07e-03 | 332 | 20 | 3 | IPR009057 | |
| Domain | Homeobox_CS | 1.67e-02 | 186 | 20 | 2 | IPR017970 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 3.03e-04 | 301 | 16 | 4 | MM15983 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 5.93e-08 | 167 | 22 | 5 | 20362541 | |
| Pubmed | 2.03e-07 | 425 | 22 | 6 | 24999758 | ||
| Pubmed | 2.13e-07 | 83 | 22 | 4 | 28794006 | ||
| Pubmed | 2.49e-07 | 20 | 22 | 3 | 11877444 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 8758910 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 12087094 | ||
| Pubmed | Identification of a tandem duplicated array in the Rhox alpha locus on mouse chromosome X. | 3.82e-07 | 2 | 22 | 2 | 16465597 | |
| Pubmed | Rhox homeobox gene cluster: recent duplication of three family members. | 3.82e-07 | 2 | 22 | 2 | 16496311 | |
| Pubmed | Cloning and characterization of the 5'-flanking region of the Ehox gene. | 3.82e-07 | 2 | 22 | 2 | 16414020 | |
| Pubmed | 6.19e-07 | 268 | 22 | 5 | 33640491 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 18562707 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 18077458 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 11851396 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 15707895 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.33e-06 | 351 | 22 | 5 | 38297188 | |
| Pubmed | 3.56e-06 | 1103 | 22 | 7 | 34189442 | ||
| Pubmed | Expression of a novel homeobox gene Ehox in trophoblast stem cells and pharyngeal pouch endoderm. | 3.82e-06 | 5 | 22 | 2 | 14648851 | |
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 15063128 | ||
| Pubmed | 1.37e-05 | 9 | 22 | 2 | 19176441 | ||
| Pubmed | 1.71e-05 | 10 | 22 | 2 | 21972064 | ||
| Pubmed | 2.09e-05 | 11 | 22 | 2 | 36613751 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 2.15e-05 | 954 | 22 | 6 | 36373674 | |
| Pubmed | 2.51e-05 | 12 | 22 | 2 | 14557543 | ||
| Pubmed | 2.51e-05 | 12 | 22 | 2 | 23011808 | ||
| Pubmed | 2.51e-05 | 12 | 22 | 2 | 29500366 | ||
| Pubmed | 3.03e-05 | 1014 | 22 | 6 | 32416067 | ||
| Pubmed | Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. | 3.46e-05 | 14 | 22 | 2 | 11500849 | |
| Pubmed | 5.81e-05 | 18 | 22 | 2 | 33842485 | ||
| Pubmed | 7.96e-05 | 21 | 22 | 2 | 19596656 | ||
| Pubmed | 9.59e-05 | 23 | 22 | 2 | 9225980 | ||
| Pubmed | 1.03e-04 | 396 | 22 | 4 | 26687479 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.04e-04 | 774 | 22 | 5 | 15302935 | |
| Pubmed | 1.05e-04 | 24 | 22 | 2 | 17182866 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.05e-04 | 398 | 22 | 4 | 35016035 | |
| Pubmed | 1.14e-04 | 25 | 22 | 2 | 21182203 | ||
| Pubmed | 1.27e-04 | 808 | 22 | 5 | 20412781 | ||
| Pubmed | 1.30e-04 | 157 | 22 | 3 | 30186101 | ||
| Pubmed | Maternal DNA Methylation Regulates Early Trophoblast Development. | 1.43e-04 | 28 | 22 | 2 | 26812015 | |
| Pubmed | Specification of jaw identity by the Hand2 transcription factor. | 1.43e-04 | 28 | 22 | 2 | 27329940 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 1.78e-04 | 457 | 22 | 4 | 32344865 | |
| Pubmed | 1.97e-04 | 469 | 22 | 4 | 27634302 | ||
| Pubmed | 2.59e-04 | 1497 | 22 | 6 | 31527615 | ||
| Pubmed | A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. | 2.86e-04 | 205 | 22 | 3 | 12040188 | |
| Pubmed | 3.24e-04 | 42 | 22 | 2 | 35705031 | ||
| Pubmed | 3.40e-04 | 43 | 22 | 2 | 26487511 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 3.52e-04 | 220 | 22 | 3 | 35785414 | |
| Pubmed | 4.59e-04 | 50 | 22 | 2 | 37974198 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 4.89e-04 | 1082 | 22 | 5 | 38697112 | |
| Pubmed | 5.11e-04 | 250 | 22 | 3 | 18660489 | ||
| Pubmed | 5.92e-04 | 263 | 22 | 3 | 20932939 | ||
| Pubmed | 6.31e-04 | 638 | 22 | 4 | 31182584 | ||
| Interaction | KLF5 interactions | 1.45e-06 | 195 | 21 | 5 | int:KLF5 | |
| Interaction | FEV interactions | 1.76e-06 | 203 | 21 | 5 | int:FEV | |
| Interaction | SOX17 interactions | 2.61e-06 | 95 | 21 | 4 | int:SOX17 | |
| Interaction | SOX9 interactions | 2.83e-06 | 97 | 21 | 4 | int:SOX9 | |
| Interaction | CRX interactions | 5.28e-06 | 254 | 21 | 5 | int:CRX | |
| Interaction | ETS1 interactions | 6.84e-06 | 121 | 21 | 4 | int:ETS1 | |
| Interaction | HNF4A interactions | 7.76e-06 | 275 | 21 | 5 | int:HNF4A | |
| Interaction | SP7 interactions | 1.26e-05 | 304 | 21 | 5 | int:SP7 | |
| Interaction | FOS interactions | 1.43e-05 | 312 | 21 | 5 | int:FOS | |
| Interaction | EWSR1 interactions | 2.42e-05 | 906 | 21 | 7 | int:EWSR1 | |
| Interaction | EGR2 interactions | 2.68e-05 | 171 | 21 | 4 | int:EGR2 | |
| Interaction | PAX6 interactions | 3.08e-05 | 366 | 21 | 5 | int:PAX6 | |
| Interaction | HNF1B interactions | 4.04e-05 | 190 | 21 | 4 | int:HNF1B | |
| Interaction | MYOD1 interactions | 4.38e-05 | 194 | 21 | 4 | int:MYOD1 | |
| Interaction | GATA2 interactions | 4.84e-05 | 199 | 21 | 4 | int:GATA2 | |
| Interaction | SOX7 interactions | 8.19e-05 | 82 | 21 | 3 | int:SOX7 | |
| Interaction | NANOG interactions | 1.12e-04 | 481 | 21 | 5 | int:NANOG | |
| Interaction | FOXI1 interactions | 1.15e-04 | 92 | 21 | 3 | int:FOXI1 | |
| Interaction | KLF6 interactions | 1.27e-04 | 95 | 21 | 3 | int:KLF6 | |
| Interaction | ESRRB interactions | 1.40e-04 | 262 | 21 | 4 | int:ESRRB | |
| Interaction | CEBPA interactions | 1.82e-04 | 1245 | 21 | 7 | int:CEBPA | |
| Interaction | THRA interactions | 2.01e-04 | 111 | 21 | 3 | int:THRA | |
| Interaction | KLF15 interactions | 2.07e-04 | 290 | 21 | 4 | int:KLF15 | |
| Interaction | TLX3 interactions | 2.10e-04 | 291 | 21 | 4 | int:TLX3 | |
| Interaction | ELF4 interactions | 2.23e-04 | 115 | 21 | 3 | int:ELF4 | |
| Interaction | TBXT interactions | 2.29e-04 | 116 | 21 | 3 | int:TBXT | |
| Interaction | PPARG interactions | 2.58e-04 | 307 | 21 | 4 | int:PPARG | |
| Interaction | ELF1 interactions | 2.92e-04 | 126 | 21 | 3 | int:ELF1 | |
| Interaction | VDR interactions | 2.99e-04 | 127 | 21 | 3 | int:VDR | |
| Interaction | PAX9 interactions | 3.20e-04 | 130 | 21 | 3 | int:PAX9 | |
| Interaction | KLF8 interactions | 3.35e-04 | 329 | 21 | 4 | int:KLF8 | |
| Interaction | SMC5 interactions | 4.19e-04 | 1000 | 21 | 6 | int:SMC5 | |
| Interaction | SUZ12 interactions | 4.36e-04 | 644 | 21 | 5 | int:SUZ12 | |
| Interaction | NCOA1 interactions | 4.50e-04 | 146 | 21 | 3 | int:NCOA1 | |
| Interaction | TOP1 interactions | 6.22e-04 | 696 | 21 | 5 | int:TOP1 | |
| Interaction | LHX4 interactions | 6.55e-04 | 166 | 21 | 3 | int:LHX4 | |
| Interaction | NUP62CL interactions | 6.74e-04 | 37 | 21 | 2 | int:NUP62CL | |
| Interaction | RXRA interactions | 6.89e-04 | 169 | 21 | 3 | int:RXRA | |
| Interaction | SETD1A interactions | 7.01e-04 | 170 | 21 | 3 | int:SETD1A | |
| Interaction | FBF1 interactions | 7.13e-04 | 171 | 21 | 3 | int:FBF1 | |
| Interaction | LHX2 interactions | 8.68e-04 | 183 | 21 | 3 | int:LHX2 | |
| Interaction | NUP35 interactions | 8.70e-04 | 424 | 21 | 4 | int:NUP35 | |
| Interaction | RNPS1 interactions | 8.78e-04 | 425 | 21 | 4 | int:RNPS1 | |
| Interaction | RORC interactions | 9.97e-04 | 45 | 21 | 2 | int:RORC | |
| Interaction | RORB interactions | 1.09e-03 | 47 | 21 | 2 | int:RORB | |
| Interaction | NR1I3 interactions | 1.13e-03 | 48 | 21 | 2 | int:NR1I3 | |
| Interaction | NR1I2 interactions | 1.13e-03 | 48 | 21 | 2 | int:NR1I2 | |
| Cytoband | Xq24 | 3.95e-04 | 64 | 21 | 2 | Xq24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq24 | 6.32e-04 | 81 | 21 | 2 | chrXq24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.95e-02 | 473 | 21 | 2 | chr17q21 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.18e-04 | 25 | 16 | 2 | 775 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 2.93e-03 | 92 | 16 | 2 | 521 | |
| GeneFamily | RNA binding motif containing | 1.49e-02 | 213 | 16 | 2 | 725 | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.32e-05 | 196 | 20 | 4 | 4773_UP | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Up 200; 3uM; PC3; HT_HG-U133A | 2.41e-05 | 198 | 20 | 4 | 2081_UP | |
| Drug | Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.41e-05 | 198 | 20 | 4 | 6315_UP | |
| Drug | Ceftazidime pentahydrate [78439-06-2]; Down 200; 6.2uM; PC3; HT_HG-U133A | 2.46e-05 | 199 | 20 | 4 | 5054_DN | |
| Drug | 2-hydroxypalmitic acid | 2.63e-05 | 9 | 20 | 2 | CID000092836 | |
| Drug | vinylene | 5.54e-05 | 245 | 20 | 4 | CID000006326 | |
| Disease | acute lymphoblastic leukemia, response to antineoplastic agent | 5.97e-05 | 19 | 18 | 2 | EFO_0000220, GO_0097327 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 1.32e-04 | 28 | 18 | 2 | DOID:4194 (implicated_via_orthology) | |
| Disease | feeling nervous measurement | 1.28e-03 | 87 | 18 | 2 | EFO_0009597 | |
| Disease | neuroblastoma | 2.25e-03 | 116 | 18 | 2 | EFO_0000621 | |
| Disease | Malignant neoplasm of breast | 3.55e-03 | 1074 | 18 | 4 | C0006142 | |
| Disease | Breast Carcinoma | 4.01e-03 | 538 | 18 | 3 | C0678222 | |
| Disease | Non-Small Cell Lung Carcinoma | 4.02e-03 | 156 | 18 | 2 | C0007131 | |
| Disease | multiple sclerosis | 5.29e-03 | 594 | 18 | 3 | MONDO_0005301 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLQQLMPTAQGGMPP | 541 | Q96L91 | |
| VVPPPTPMGMLNQQL | 1466 | Q86U86 | |
| PPAPPLPQMMEGNGN | 11 | P30419 | |
| GPLSNAMVLQPPAPM | 921 | O43150 | |
| MGQPMLPILPPQLDS | 371 | Q5T1M5 | |
| LPQNQLMMTGPKPGP | 1156 | Q14686 | |
| PLPPQGMLVQPGMNL | 566 | O15234 | |
| NQAPMLMGPPPKTGL | 776 | Q9Y6T7 | |
| NPGLPQPALGEMIQM | 1081 | P14616 | |
| MQPQLGMPGVGPVPL | 286 | Q9H0L4 | |
| QALPMGALPQGPMQN | 116 | P04233 | |
| QTVMGPGLAPMLAPP | 1091 | Q9BXA9 | |
| FPMLPKQPMLGGNPR | 876 | Q9Y6Q9 | |
| LPLMLLPPMPPAGQA | 256 | P0C7M4 | |
| NAVIQPMGPLQPGLP | 1016 | P63128 | |
| VGLPNPRMQGPIQQP | 491 | O15164 | |
| MNMPQSLGNQPLPPE | 1 | A6NDV4 | |
| LPLMLLPPMPPAGQA | 256 | Q9BQY4 | |
| PAGSPAMMLQPGPQL | 321 | Q93038 | |
| PIGGMMPPQPGIPQQ | 401 | O43670 | |
| MPPQPGIPQQQGMRP | 406 | O43670 | |
| GIPQQQGMRPPMPPH | 411 | O43670 | |
| NAVIQPMGPLQPGLP | 96 | Q9WJR5 | |
| PMGPLQPGLPSLAMI | 101 | Q9WJR5 | |
| PPGAMPPQQLMPGQM | 181 | P09012 |